tiprankstipranks
Trending News
More News >
Medtronic (MDT)
NYSE:MDT
US Market

Medtronic (MDT) Ratios

Compare
6,344 Followers

Medtronic Ratios

MDT's free cash flow for Q2 2026 was $0.60. For the 2026 fiscal year, MDT's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.42 2.03 2.39 1.86 2.65
Quick Ratio
2.42 1.55 1.81 1.49 2.14
Cash Ratio
0.13 0.12 0.17 0.30 0.42
Solvency Ratio
0.18 0.16 0.16 0.20 0.15
Operating Cash Flow Ratio
0.72 0.63 0.67 0.59 0.73
Short-Term Operating Cash Flow Coverage
5.01 6.25 464.54 1.97 3.12K
Net Current Asset Value
$ -18.49B$ -17.63B$ -17.61B$ -15.20B$ -18.93B
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.28 0.27 0.27 0.28
Debt-to-Equity Ratio
0.60 0.50 0.47 0.46 0.51
Debt-to-Capital Ratio
0.37 0.33 0.32 0.31 0.34
Long-Term Debt-to-Capital Ratio
0.36 0.32 0.32 0.28 0.34
Financial Leverage Ratio
1.88 1.79 1.77 1.73 1.81
Debt Service Coverage Ratio
3.93 3.92 10.62 2.12 8.55
Interest Coverage Ratio
8.75 7.15 8.62 10.40 4.85
Debt to Market Cap
0.22 0.24 0.20 0.17 0.15
Interest Debt Per Share
23.26 19.39 18.80 18.38 20.31
Net Debt to EBITDA
3.00 2.89 2.69 2.14 2.78
Profitability Margins
Gross Profit Margin
62.27%65.34%65.67%67.98%65.19%
EBIT Margin
18.44%17.17%19.21%19.16%16.00%
EBITDA Margin
26.67%25.35%27.14%30.15%27.20%
Operating Profit Margin
17.87%15.89%17.56%18.15%14.89%
Pretax Profit Margin
16.40%14.95%17.18%17.41%12.93%
Net Profit Margin
13.71%11.36%12.03%15.90%11.97%
Continuous Operations Profit Margin
13.79%11.44%12.12%15.98%12.05%
Net Income Per EBT
83.61%76.00%70.06%91.34%92.58%
EBT Per EBIT
91.74%94.03%97.79%95.91%86.86%
Return on Assets (ROA)
5.22%4.09%4.13%5.54%3.87%
Return on Equity (ROE)
9.83%7.32%7.30%9.59%7.01%
Return on Capital Employed (ROCE)
7.63%6.50%6.70%7.32%5.30%
Return on Invested Capital (ROIC)
6.31%4.91%4.71%6.41%4.93%
Return on Tangible Assets
12.29%10.28%10.84%14.45%10.80%
Earnings Yield
3.53%3.47%3.11%3.60%2.05%
Efficiency Ratios
Receivables Turnover
0.00 5.28 5.21 5.71 5.51
Payables Turnover
0.00 4.65 4.03 4.46 4.98
Inventory Turnover
0.00 2.15 2.03 2.20 2.43
Fixed Asset Turnover
0.00 5.28 5.61 5.85 5.77
Asset Turnover
0.38 0.36 0.34 0.35 0.32
Working Capital Turnover Ratio
2.70 2.72 2.68 2.57 2.34
Cash Conversion Cycle
0.00 160.46 159.70 148.13 143.04
Days of Sales Outstanding
0.00 69.11 70.11 63.94 66.20
Days of Inventory Outstanding
0.00 169.78 180.24 166.08 150.17
Days of Payables Outstanding
0.00 78.43 90.65 81.89 73.33
Operating Cycle
0.00 238.89 250.34 230.02 216.37
Cash Flow Ratios
Operating Cash Flow Per Share
5.55 5.11 4.54 5.47 4.64
Free Cash Flow Per Share
4.06 3.92 3.44 4.45 3.63
CapEx Per Share
1.49 1.20 1.10 1.02 1.01
Free Cash Flow to Operating Cash Flow
0.73 0.77 0.76 0.81 0.78
Dividend Paid and CapEx Coverage Ratio
1.29 1.29 1.19 1.55 1.39
Capital Expenditure Coverage Ratio
3.73 4.28 4.14 5.37 4.61
Operating Cash Flow Coverage Ratio
0.24 0.27 0.25 0.30 0.24
Operating Cash Flow to Sales Ratio
0.20 0.21 0.19 0.23 0.21
Free Cash Flow Yield
3.85%4.91%3.79%4.27%2.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.34 28.80 32.18 27.80 48.83
Price-to-Sales (P/S) Ratio
3.89 3.27 3.87 4.42 5.85
Price-to-Book (P/B) Ratio
2.78 2.11 2.35 2.67 3.42
Price-to-Free Cash Flow (P/FCF) Ratio
25.96 20.36 26.41 23.43 36.04
Price-to-Operating Cash Flow Ratio
18.98 15.60 20.03 19.07 28.22
Price-to-Earnings Growth (PEG) Ratio
12.86 -13.58 -1.31 0.70 -1.96
Price-to-Fair Value
2.78 2.11 2.35 2.67 3.42
Enterprise Value Multiple
17.58 15.80 16.96 16.80 24.28
Enterprise Value
162.95B 129.61B 143.77B 160.49B 198.87B
EV to EBITDA
17.58 15.80 16.96 16.80 24.28
EV to Sales
4.69 4.00 4.60 5.07 6.60
EV to Free Cash Flow
31.30 24.93 31.39 26.85 40.71
EV to Operating Cash Flow
22.91 19.10 23.81 21.85 31.87
Tangible Book Value Per Share
-2.91 -2.86 -3.46 -2.51 -6.02
Shareholders’ Equity Per Share
37.96 37.82 38.71 39.15 38.24
Tax and Other Ratios
Effective Tax Rate
0.16 0.23 0.29 0.08 0.07
Revenue Per Share
27.12 24.38 23.48 23.60 22.39
Net Income Per Share
3.72 2.77 2.83 3.75 2.68
Tax Burden
0.84 0.76 0.70 0.91 0.93
Interest Burden
0.89 0.87 0.89 0.91 0.81
Research & Development to Revenue
0.08 0.08 0.09 0.09 0.08
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.01 0.01
Income Quality
1.49 1.85 1.60 1.45 1.72
Currency in USD